Profile of a serial killer: Cellular and molecular approaches to study individual cytotoxic T-cells following therapeutic vaccination

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Speiser, Daniel E ^a   Iancu, Emanuela M ^a   Baumgaertner, Petra ^a   Wieckowski, Sébastien ^a   Rufer, Nathalie ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; GAMMA INTERFERON; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELAN A; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; CANCER VACCINE; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; CANCER THERAPY; CD8+ T LYMPHOCYTE; CELL CLONING; CELLULAR IMMUNITY; CYTOLOGY; CYTOLYSIS; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; IMMUNOTHERAPY; INFECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE TRANSFER; MELANOMA; MEMORY CELL; NONHUMAN; PHENOTYPE; REVIEW; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY; VACCINATION; ANIMAL; CELL DIFFERENTIATION; IMMUNE SYSTEM; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; MOUSE; NEOPLASM; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC);

ANIMALS; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; GENE EXPRESSION PROFILING; HUMANS; IMMUNE SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; MICE; NEOPLASMS; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 78650757023     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/452606     Document Type: Review

References (142)

1. Lasithiotakis K. G., Petrakis I. E., Garbe C., Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment Melanoma Research 2010 20 3 163 170
2. Boon T., Coulie P. G., Van Den Eynde B. J., Van Der Bruggen P., Human T cell responses against melanoma Annual Review of Immunology 2006 24 175 208
3. Speiser D. E., Linard D., Pittet M. J., Batard P., Rimoldi D., Guillaume P., Cerottini J.-C., Romero P., In vivo activation of melanoma-specific CD8+ T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells European Journal of Immunology 2002 32 3 731 741
4. Linard D., Rimoldi D., Marchand M., Dietrich P. Y., van Baren N., Geldhof C., Batard P., Guillaume P., Ayyoub M., Pittet M. J., Zippelius A., Fleischhauer K., Lejeune F., Cerottini J. C., Romero P., Speiser D. E., Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA Cancer Immunity 2004 4 4
5. Romero P., Dunbar P. R., Valmori D., Pittet M., Ogg G. S., Rimoldi D., Chen J.-L., Linard D., Cerottini J.-C., Cerundolo V., Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen- experienced tumor-specific cytolytic T lymphocytes Journal of Experimental Medicine 1998 188 9 1641 1650
6. Romero P., Valmori D., Pittet M. J., Zippelius A., Rimoldi D., Lvy F., Dutoit V., Ayyoub M., Rubio-Godoy V., Michielin O., Guillaume P., Batard P., Luescher I. F., Lejeune F., Linard D., Rufer N., Dietrich P.-Y., Speiser D. E., Cerottini J.-C., Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma Immunological Reviews 2002 188 81 96
7. Dutoit V., Rubio-Godoy V., Pittet M. J., Zippelius A., Dietrich P.-Y., Legal F. A., Guillaume P., Romero P., Cerottini J.-C., Houghten R. A., Pinilla C., Valmori D., Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-A peptide multimer + CD8+ T cells in humans Journal of Experimental Medicine 2002 196 2 207 216
8. Zippelius A., Pittet M. J., Batard P., Rufer N., De Smedt M., Guillaume P., Ellefsen K., Valmori D., Linard D., Plum J., Robson MacDonald H., Speiser D. E., Cerottini J.-C., Romero P., Thymic selection generates a large T cell pool recognizing a self-peptide in humans Journal of Experimental Medicine 2002 195 4 485 494
9. Beutler B., Inferences, questions and possibilities in Toll-like receptor signalling Nature 2004 430 6996 257 263
10. Germain R. N., An innately interesting decade of research in immunology Nature Medicine 2004 10 12 1307 1320
11. Janeway C. A. Jr., Medzhitov R., Innate immune recognition Annual Review of Immunology 2002 20 197 216
12. Takeda K., Kaisho T., Akira S., Toll-like receptors Annual Review of Immunology 2003 21 335 376
13. Speiser D. E., Linard D., Rufer N., Rubio-Godoy V., Rimoldi D., Lejeune F., Krieg A. M., Cerottini J.-C., Romero P., Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909 Journal of Clinical Investigation 2005 115 3 739 746
14. Speiser D. E., Baumgaertner P., Voelter V., Devevre E., Barbey C., Rufer N., Romero P., Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen Proceedings of the National Academy of Sciences of the United States of America 2008 105 10 3849 3854
15. Dudley M. E., Wunderlich J. R., Robbins P. F., Yang J. C., Hwu P., Schwartzentruber D. J., Topalian S. L., Sherry R., Restifo N. P., Hubicki A. M., Robinson M. R., Raffeld M., Duray P., Seipp C. A., Rogers-Freezer L., Morton K. E., Mavroukakis S. A., White D. E., Rosenberg S. A., Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 2002 298 5594 850 854
16. Dudley M. E., Wunderlich J. R., Yang J. C., Sherry R. M., Topalian S. L., Restifo N. P., Royal R. E., Kammula U., White D. E., Mavroukakis S. A., Rogers L. J., Gracia G. J., Jones S. A., Mangiameli D. P., Pelletier M. M., Gea-Banacloche J., Robinson M. R., Berman D. M., Filie A. C., Abati A., Rosenberg S. A., Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma Journal of Clinical Oncology 2005 23 10 2346 2357
17. Altman J. D., Moss P. A. H., Goulder P. J. R., Barouch D. H., McHeyzer-Williams M. G., Bell J. I., McMichael A. J., Davis M. M., Phenotypic analysis of antigen-specific T lymphocytes Science 1996 274 5284 94 96
18. Klenerman P., Cerundolo V., Dunbar P. R., Tracking T cells with tetramers: new tales from new tools Nature Reviews Immunology 2002 2 4 263 272
19. Derr L., Jandus C., Baumgaertner P., Posevitz V., Devvre E., Romero P., Speiser D. E., Quantitative multiparameter assays to measure the effect of adjuvants on human antigen-specific CD8 T-cell responses Methods in Molecular Biology 2010 626 231 249
20. Volkert M., Marker O., Bro-Jorgensen K., Twp populations of T lymphocytes immune to the lymphocytic choriomeningitis virus Journal of Experimental Medicine 1974 139 5 1329 1343
21. Ahmed R., Gray D., Immunological memory and protective immunity: understanding their relation Science 1996 272 5258 54 60
22. Sallusto F., Lenig D., Frster R., Lipp M., Lanzavecchia A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 1999 401 6754 708 712
23. Sallusto F., Geginat J., Lanzavecchia A., Central memory and effector memory T cell subsets: function, generation, and maintenance Annual Review of Immunology 2004 22 745 763
24. Sallusto F., Palermo B., Hoy A., Lanzavecchia A., The role of chemokine receptors in directing traffic of naive, type 1 and type 2 T cells Current Topics in Microbiology and Immunology 1999 246 123 129
25. Gillespie G. M. A., Wills M. R., Appay V., O'Callaghan C., Murphy M., Smith N., Sissons P., Rowland-Jones S., Bell J. I., Moss P. A. H., Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8+ T lymphocytes in healthy seropositive donors Journal of Virology 2000 74 17 8140 8150
26. Hislop A. D., Gudgeon N. H., Callan M. F. C., Fazou C., Hasegawa H., Salmon M., Rickinson A. B., EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function Journal of Immunology 2001 167 4 2019 2029
27. Champagne P., Ogg G. S., King A. S., Knabenhans C., Ellefsen K., Nobile M., Appay V., Rizzardi G. P., Fleury S., Lipp M., Frster R., Rowland-Jones S., Skaly R.-P., McMichael A. J., Pantaleo G., Skewed maturation of memory HIV-specific CD8 T lymphocytes Nature 2001 410 6824 106 111
28. Gamadia L. E., Rentenaar R. J., Baars P. A., Remmerswaal E. B. M., Surachno S., Weel J. F. L., Toebes M., Schumacher T. N. M., Ten Berge I. J. M., Van Lier R. A. W., Differentiation of cytomegalovirus-specific CD8+ T cells in healthy and immunosuppressed virus carriers Blood 2001 98 3 754 761
29. Appay V., Dunbar P. R., Callan M., Klenerman P., Gillespie G. M. A., Papagno L., Ogg G. S., King A., Lechner F., Spina C. A., Little S., Havlir D. V., Richman D. D., Gruener N., Pape G., Waters A., Easterbrook P., Salio M., Cerundolo V., McMichael A. J., Rowland-Jones S. L., Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections Nature Medicine 2002 8 4 379 385
30. Papagno L., Spina C. A., Marchant A., Salio M., Rufer N., Little S., Dong T., Chesney G., Waters A., Easterbrook P., Dunbar P. R., Shepherd D., Cerundolo V., Emery V., Griffiths P., Conlon C., McMichael A. J., Richman D. D., Rowland-Jones S. L., Appay V., Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection PLoS Biology 2004 2 2, article no. E20
31. Tomiyama H., Takata H., Matsuda T., Takiguchi M., Phenotypic classification of human CD8+ T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function European Journal of Immunology 2004 34 4 999 1010
32. Rufer N., Zippelius A., Batard P., Pittet M. J., Kurth I., Corthesy P., Cerottini J.-C., Leyvraz S., Roosnek E., Nabholz M., Romero P., Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions Blood 2003 102 5 1779 1787
33. Monteiro M., Evaristo C., Legrand A., Nicoletti A., Rocha B., Cartography of gene expression in CD8 single cells: novel CCR7- subsets suggest differentiation independent of CD45RA expression Blood 2007 109 7 2863 2870
34. Romero P., Zippelius A., Kurth I., Pittet M. J., Touvrey C., Iancu E. M., Corthesy P., Devevre E., Speiser D. E., Rufer N., Four functionally distinct populations of human effector-memory CD8 + T lymphocytes Journal of Immunology 2007 178 7 4112 4119
35. Hislop A. D., Annels N. E., Gudgeon N. H., Leese A. M., Rickinson A. B., Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein-Barr virus infection Journal of Experimental Medicine 2002 195 7 893 905
36. Chen G., Shankar P., Lange C., Valdez H., Skolnik P. R., Wu L., Manjunath N., Lieberman J., CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection Blood 2001 98 1 156 164
37. Khan N., Cobbold M., Keenan R., Moss P. A. H., Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype Journal of Infectious Diseases 2002 185 8 1025 1034
38. Wills M. R., Okecha G., Weekes M. P., Gandhi M. K., Sissons P. J. G., Carmichael A. J., Identification of naive or antigen-experienced human CD8+ T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8+ T cell response Journal of Immunology 2002 168 11 5455 5464
39. Rocha B., Tanchot C., The Tower of Babel of CD8+ T-cell memory: known facts, deserted roads, muddy waters, and possible dead ends Immunological Reviews 2006 211 182 196
40. Wiesel M., Walton S., Richter K., Oxenius A., Virus-specific CD8 T cells: activation, differentiation and memory formation Acta Pathologica, Microbiologica. et Immunologica Scandinavica 2009 117 5-6 356 381
41. Chattopadhyay P. K., Roederer M., Good cell, bad cell: flow cytometry reveals T-cell subsets important in HIV disease Cytometry Part A 2010 77 7 614 622
42. Speiser D. E., Migliaccio M., Pittet M. J., Valmori D., Linard D., Lejeune F., Reichenbach P., Guillaume P., Lscher I., Cerottini J.-C., Romero P., Human CD8+ T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells European Journal of Immunology 2001 31 2 459 466
43. Iancu E. M., Corthesy P., Baumgaertner P., Devevre E., Voelter V., Romero P., Speiser D. E., Rufer N., Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time Journal of Immunology 2009 183 1 319 331
44. Touvrey C., Derr L., Devevre E., Corthesy P., Romero P., Rufer N., Speiser D. E., Dominant human CD8 T cell clonotypes persist simultaneously as memory and effector cells in memory phase Journal of Immunology 2009 182 11 6718 6726
45. Speiser D. E., Baumgaertner P., Barbey C., Rubio-Godoy V., Moulin A., Corthesy P., Devevre E., Dietrich P.-Y., Rimoldi D., Linard D., Cerottini J.-C., Romero P., Rufer N., A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination Journal of Immunology 2006 177 2 1338 1348
46. Derr L., Ferber M., Touvrey C., Devevre E., Zoete V., Leimgruber A., Romero P., Michielin O., Lvy F., Speiser D. E., A novel population of human melanoma-specific CD8 T cells recognizes melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide Journal of Immunology 2007 179 11 7635 7645
47. Barbey C., Baumgaertner P., Devevre E., Rubio-Godoy V., Derre L., Bricard G., Guillaume P., Luescher I. F., Linard D., Cerottini J.-C., Romero P., Rufer N., Speiser D. E., IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cells Journal of Immunology 2007 178 6 3566 3574
48. Derr L., Bruyninx M., Baumgaertner P., Devevre E., Corthesy P., Touvrey C., Mahnke Y. D., Pircher H., Voelter V., Romero P., Speiser D. E., Rufer N., In vivo persistence of codominant human CD8+ T cell clonotypes is not limited by replicative senescence or functional alteration Journal of Immunology 2007 179 4 2368 2379
49. Derr L., Bruyninx M., Baumgaertner P., Ferber M., Schmid D., Leimgruber A., Zoete V., Romero P., Michielin O., Speiser D. E., Rufer N., Distinct sets of TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues Proceedings of the National Academy of Sciences of the United States of America 2008 105 39 15010 15015
50. Appay V., Jandus C., Voelter V., Reynard S., Coupland S. E., Rimoldi D., Lienard D., Guillaume P., Krieg A. M., Cerottini J.-C., Romero P., Leyvraz S., Rufer N., Speiser D. E., New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site Journal of Immunology 2006 177 3 1670 1678
51. Wieckowski S., Baumgaertner P., Corthesy P., Fine structural variations of alphabetaTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients The Journal of Immunology 2009 183 5397 5406
52. Voelter V., Pica A., Laurent J., Rimoldi D., Bouzourene H., Sajadi A., Matter M., Romero P., Rufer N., Speiser D. E., An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain Cancer Immunity 2008 8 6
53. Chattopadhyay P. K., Betts M. R., Price D. A., Gostick E., Horton H., Roederer M., De Rosa S. C., The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression Journal of Leukocyte Biology 2009 85 1 88 97
54. Sallusto F., Lanzavecchia A., Exploring pathways for memory T cell generation Journal of Clinical Investigation 2001 108 6 805 806
55. Lanzavecchia A., Sallusto F., Understanding the generation and function of memory T cell subsets Current Opinion in Immunology 2005 17 3 326 332
56. Gett A. V., Sallusto F., Lanzavecchia A., Geginat J., T cell fitness determined by signal strength Nature Immunology 2003 4 4 355 360
57. Bachmann M. F., Wolint P., Schwarz K., Oxenius A., Recall proliferation potential of memory CD8+ T cells and antiviral protection Journal of Immunology 2005 175 7 4677 4685
58. Roberts A. D., Ely K. H., Woodland D. L., Differential contributions of central and effector memory T cells to recall responses Journal of Experimental Medicine 2005 202 1 123 133
59. Wherry E. J., Teichgrber V., Becker T. C., Masopust D., Kaech S. M., Antia R., von Andrian U. H., Ahmed R., Lineage relationship and protective immunity of memory CD8T cell subsets Nature Immunology 2003 4 3 225 234
60. Newell E. W., Klein L. O., Yu W., Davis M. M., Simultaneous detection of many T-cell specificities using combinatorial tetramer staining Nature Methods 2009 6 7 497 499
61. Hadrup S. R., Bakker A. H., Shu C. J., Andersen R. S., van Veluw J., Hombrink P., Castermans E., thor Straten P., Blank C., Haanen J. B., Heemskerk M. H., Schumacher T. N., Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers Nature Methods 2009 6 7 520 526
62. Ayyoub M., Dojcinovic D., Pignon P., Raimbaud I., Schmidt J., Luescher I., Valmori D., Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramers Proceedings of the National Academy of Sciences of the United States of America 2010 107 16 7437 7442
63. Makedonas G., Hutnick N., Haney D., Amick A. C., Gardner J., Cosma G., Hersperger A. R., Dolfi D., Wherry E. J., Ferrari G., Betts M. R., Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8+ T cells PLoS Pathogens 2010 6 3, article no. e1000798
64. Brunner K. T., Mauel J., Cerottini J. C., Chapuis B., Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs Immunology 1968 14 2 181 196
65. Pittet M. J., Rubio-Godoy V., Bioley G., Guillaume P., Batard P., Speiser D., Luescher I., Cerottini J.-C., Romero P., Zippelius A., 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells Journal of Immunology 2003 171 4 1844 1849
66. Zaritskaya L., Shurin M. R., Sayers T. J., Malyguine A. M., New flow cytometric assays for monitoring cell-mediated cytotoxicity Expert Review of Vaccines 2010 9 6 601 616
67. Betts M. R., Brenchley J. M., Price D. A., De Rosa S. C., Douek D. C., Roederer M., Koup R. A., Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation Journal of Immunological Methods 2003 281 1-2 65 78
68. Devvre E., Romero P., Mahnke Y. D., LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8+ T-cells by flow cytometry Journal of Immunological Methods 2006 311 1-2 31 46
69. Appay V., Speiser D. E., Rufer N., Reynard S., Barbey C., Cerottini J.-C., Leyvraz S., Pinilla C., Romero P., Decreased specific CD8+ T cell cross-reactivity of antigen recognition following vaccination with Melan-A peptide European Journal of Immunology 2006 36 7 1805 1814
70. Rubio-Godoy V., Dutoit V., Zhao Y., Simon R., Guillaume P., Houghten R., Romero P., Cerottini J.-C., Pinilla C., Valmori D., Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL Journal of Immunology 2002 169 10 5696 5707
71. Rufer N., Dragowska W., Thornbury G., Roosnek E., Lansdorp P. M., Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry Nature Biotechnology 1998 16 8 743 747 (Pubitemid 28363755)
72. Rufer N., Brmmendorf T. H., Kolvraa S., Bischoff C., Christensen K., Wadsworth L., Schulzer M., Lansdorp P. M., Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood Journal of Experimental Medicine 1999 190 2 157 167
73. Baird D. M., Rowson J., Wynford-Thomas D., Kipling D., Extensive allelic variation and ultrashort telomeres in senescent human cells Nature Genetics 2003 33 2 203 207
74. Iancu E. M., Speiser D. E., Rufer N., Assessing ageing of individual T lymphocytes: mission impossible? Mechanisms of Ageing and Development 2008 129 1-2 67 78
75. Douek D. C., McFarland R. D., Keiser P. H., Gage E. A., Massey J. M., Haynes B. F., Polis M. A., Haase A. T., Feinberg M. B., Sullivan J. L., Jamieson B. D., Zack J. A., Picker L. J., Koup R. A., Changes in thymic function with age and during the treatment of HIV infection Nature 1998 396 6712 690 695
76. Critchley-Thorne R. J., Yan N., Nacu S., Weber J., Holmes S. P., Lee P. P., Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma. PLoS Medicine 2007 4 5, article no. e176
77. Perez O. D., Mitchell D., Jager G. C., South S., Murriel C., McBride J., Herzenberg L. A., Kinoshita S., Nolan G. P., Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1 Nature Immunology 2003 4 11 1083 1092
78. Kuss I., Rabinowich H., Gooding W., Edwards R., Whiteside T. L., Expression of in T cells prior to interleukin-2 therapy as a predictor of response and survival in patients with ovarian carcinoma Cancer Biotherapy and Radiopharmaceuticals 2002 17 6 631 640
79. Whiteside T. L., Down-regulation of -chain expression in T cells: a biomarker of prognosis in cancer? Cancer Immunology, Immunotherapy 2004 53 10 865 878
80. Dunbar P. R., Smith C. L., Chao D., Salio M., Shepherd D., Mirza F., Lipp M., Lanzavecchia A., Sallusto F., Evans A., Russell-Jones R., Harris A. L., Cerundolo V., A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response Journal of Immunology 2000 165 11 6644 6652
81. Mortarini R., Piris A., Maurichi A., Molla A., Bersani I., Bono A., Bartoli C., Santinami M., Lombardo C., Ravagnani F., Cascinelli N., Parmiani G., Anichini A., Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma Cancer Research 2003 63 10 2535 2545
82. Zippelius A., Batard P., Rubio-Godoy V., Bioley G., Linard D., Lejeune F., Rimoldi D., Guillaume P., Meidenbauer N., Mackensen A., Rufer N., Lubenow N., Speiser D., Cerottini J.-C., Romero P., Pittet M. J., Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance Cancer Research 2004 64 8 2865 2873
83. Ahmadzadeh M., Johnson L. A., Heemskerk B., Wunderlich J. R., Dudley M. E., White D. E., Rosenberg S. A., Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired Blood 2009 114 8 1537 1544
84. Ahmadzadeh M., Felipe-Silva A., Heemskerk B., Powell D. J. Jr., Wunderlich J. R., Merino M. J., Rosenberg S. A., FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions Blood 2008 112 13 4953 4960
85. Beyer M., Karbach J., Mallmann M. R., Zander T., Eggle D., Classen S., Debey-Pascher S., Famulok M., Jger E., Schultze J. L., Cancer vaccine enhanced, non-tumor-reactive CD8+ T cells exhibit a distinct molecular program associated with "division arrest anergy" Cancer Research 2009 69 10 4346 4354
86. Rufer N., Molecular tracking of antigen-specific T-cell clones during immune responses Current Opinion in Immunology 2005 17 4 441 447
87. Appay V., Bosio A., Lokan S., Wiencek Y., Biervert C., Ksters D., Devevre E., Speiser D., Romero P., Rufer N., Leyvraz S., Sensitive gene expression profiling of human T cell subsets reveals parallel post-thymic differentiation for CD4 + and CD8+ lineages Journal of Immunology 2007 179 11 7406 7414
88. Rufer N., Reichenbach P., Romero P., Methods for the ex vivo characterization of human CD8+ T subsets based on gene expression and replicative history analysis Methods in Molecular Medicine 2005 109 265 284
89. Peixoto A., Monteiro M., Rocha B., Veiga-Fernandes H., Quantification of multiple gene expression in individual cells Genome Research 2004 14 10 1938 1947
90. Peixoto A., Evaristo C., Munitic I., Monteiro M., Charbit A., Rocha B., Veiga-Fernandes H., CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response Journal of Experimental Medicine 2007 204 5 1193 1205
91. Esumi S., Wu S.-X., Yanagawa Y., Obata K., Sugimoto Y., Tamamaki N., Method for single-cell microarray analysis and application to gene-expression profiling of GABAergic neuron progenitors Neuroscience Research 2008 60 4 439 451
92. Fiesel F. C., Voigt A., Weber S. S., Van den Haute C., Waldenmaier A., Grner K., Walter M., Anderson M. L., Kern J. V., Rasse T. M., Schmidt T., Springer W., Kirchner R., Bonin M., Neumann M., Baekelandt V., Alunni-Fabbroni M., Schulz J. B., Kahle P. J., Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6 The EMBO Journal 2010 29 1 209 221
93. Waak J., Weber S. S., Waldenmaier A., Grner K., Alunni-Fabbroni M., Schell H., Vogt-Weisenhorn D., Pham T.-T., Reumers V., Baekelandt V., Wurst W., Kahle P. J., Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1 FASEB Journal 2009 23 8 2478 2489
94. Alunni-Fabbroni M., Sandri M. T., Circulating tumour cells in clinical practice: methods of detection and possible characterization Methods 2010 50 4 289 297
95. Mayer V., Schoen U., Holinski-Feder E., Koehler U., Thalhammer S., Single cell analysis of mutations in the APC gene Fetal Diagnosis and Therapy 2009 26 148 156
96. Woide D., Mayer V., Wachtmeister T., Hoehn N., Zink A., Koehler U., Thalhammer S., Single particle adsorbing transfer system Biomedical Microdevices 2009 11 3 609 614
97. Lutz-Bonengel S., Snger T., Parson W., Mller H., Ellwart J. W., Follo M., Bonengel B., Niedersttter H., Heinrich M., Schmidt U., Single lymphocytes from two healthy individuals with mitochondrial point heteroplasmy are mainly homoplasmic International Journal of Legal Medicine 2008 122 3 189 197
98. Kroneis T., Gutstein-Abo L., Kofler K., Hartmann M., Hartmann P., Alunni-Fabbroni M., Walcher W., Dohr G., Petek E., Guetta E., Sedlmayr P., Automatic retrieval of single microchimeric cells and verification of identity by on-chip multiplex PCR Journal of Cellular and Molecular Medicine 2010 14 4 954 969
99. Holodick N. E., Repetny K., Zhong X., Rothstein T. L., Adult BM generates CD5+ B1 cells containing abundant N-region additions European Journal of Immunology 2009 39 9 2383 2394
100. Pannetier C., Even J., Kourilsky P., T-cell repertoire diversity and clonal expansions in normal and clinical samples Immunology Today 1995 16 4 176 181
101. Roux E., Helg C., Dumont-Girard F., Chapuis B., Jeannet M., Roosnek E., Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts Blood 1996 87 9 3984 3992
102. Turner S. J., Kedzierska K., La Gruta N. L., Webby R., Doherty P. C., Characterization of CD8+ T cell repertoire diversity and persistence in the influenza a virus model of localized, transient infection Seminars in Immunology 2004 16 3 179 184
103. Maryanski J. L., Jongeneel C. V., Bucher P., Casanova J.-L., Walker P. R., Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones Immunity 1996 4 1 47 55
104. Turner S. J., Diaz G., Cross R., Doherty P. C., Analysis of clonotype distribution and persistence for an influenza virus-specific CD8+ T cell response Immunity 2003 18 4 549 559
105. Kedzierska K., Turner S. J., Doherty P. C., Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope Proceedings of the National Academy of Sciences of the United States of America 2004 101 14 4942 4947
106. Kaech S. M., Wherry E. J., Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection Immunity 2007 27 3 393 405
107. Wherry E. J., Ha S.-J., Kaech S. M., Haining W. N., Sarkar S., Kalia V., Subramaniam S., Blattman J. N., Barber D. L., Ahmed R., Molecular signature of CD8+ T cell exhaustion during chronic viral infection Immunity 2007 27 4 670 684
108. Stemberger C., Huster K. M., Koffler M., Anderl F., Schiemann M., Wagner H., Busch D. H., A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets Immunity 2007 27 6 985 997
109. Kedzierska K., Venturi V., Field K., Davenport M. P., Turner S. J., Doherty P. C., Early establishment of diverse T cell receptor profiles for influenza-specific CD8+ CD 62Lhi memory T cells Proceedings of the National Academy of Sciences of the United States of America 2006 103 24 9184 9189
110. Bouneaud C., Garcia Z., Kourilsky P., Pannetier C., Lineage relationships, homeostasis, and recall capacities of central- and effector-memory CD8 T cells in vivo Journal of Experimental Medicine 2005 201 4 579 590
111. Baron V., Bouneaud C., Cumano A., Lim A., Arstila T. P., Kourilsky P., Ferradini L., Pannetier C., The repertoires of circulating human CD8+ central and effector memory T cell subsets are largely distinct Immunity 2003 18 2 193 204
112. Lefranc M.-P., Giudicelli V., Ginestoux C., Bodmer J., Mller W., Bontrop R., Lemaitre M., Malik A., Barbi V., Chaume D., IMGT, the international ImMunoGeneTics database Nucleic Acids Research 1999 27 1 209 212
113. Douek D. C., Betts M. R., Brenchley J. M., Hill B. J., Ambrozak D. R., Ngai K.-L., Karandikar N. J., Casazza J. P., Koup R. A., A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape Journal of Immunology 2002 168 6 3099 3104
114. Price D. A., Asher T. E., Wilson N. A., Nason M. C., Brenchley J. M., Metzler I. S., Venturi V., Gostick E., Chattopadhyay P. K., Roederer M., Davenport M. P., Watkins D. I., Douek D. C., Public clonotype usage identifies protective gag-specific CD8+ t cell responses in SIV infection Journal of Experimental Medicine 2009 206 4 923 936
115. Venturi V., Hui Y. C., Price D. A., Douek D. C., Davenport M. P., The role of production frequency in the sharing of simian immunodeficiency virus-specific CD8+ TCRs between macaques Journal of Immunology 2008 181 4 2597 2609
116. Price D. A., West S. M., Betts M. R., Ruff L. E., Brenchley J. M., Ambrozak D. R., Edghill-Smith Y., Kuroda M. J., Bogdan D., Kunstman K., Letvin N. L., Franchini G., Wolinsky S. M., Koup R. A., Douek D. C., T cell receptor recognition motifs govern immune escape patterns in acute SIV infection Immunity 2004 21 6 793 803
117. Smith M. Z., Asher T. E., Venturi V., Davenport M. P., Douek D. C., Price D. A., Kent S. J., Limited maintenance of vaccine-induced simian immunodeficiency virus-specific CD8 T-cell receptor clonotypes after virus challenge Journal of Virology 2008 82 15 7357 7368
118. Almeida J. R., Price D. A., Papagno L., Arkoub Z. A., Sauce D., Bornstein E., Asher T. E., Samri A., Schnuriger A., Theodorou I., Costagliola D., Rouzioux C., Agut H., Marcelin A.-G., Douek D., Autran B., Appay V., Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover Journal of Experimental Medicine 2007 204 10 2473 2485
119. Schaubert K. L., Price D. A., Salkowitz J. R., Sewell A. K., Sidney J., Asher T. E., Blondelle S. E., Adams S., Marincola F. M., Joseph A., Sette A., Douek D. C., Ayyavoo V., Storkus W., Leung M.-Y., Ng H. L., Yang O. O., Goldstein H., Wilson D. B., Kan-Mitchell J., Generation of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes European Journal of Immunology 2010 40 7 1950 1962
120. Almeida J. R., Sauce D., Price D. A., Papagno L., So Y. S., Moris A., Larsen M., Pancino G., Douek D. C., Autran B., Sez-Cirin A., Appay V., Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity Blood 2009 113 25 6351 6360
121. Geldmacher C., Metzler I. S., Tovanabutra S., Asher T. E., Gostick E., Ambrozak D. R., Petrovas C., Schuetz A., Ngwenyama N., Kijak G., Maboko L., Hoelscher M., McCutchan F., Price D. A., Douek D. C., Koup R. A., Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response Blood 2009 114 8 1553 1562
122. Schaubert K. L., Price D. A., Frahm N., Li J., Ng H. L., Joseph A., Paul E., Majumder B., Ayyavoo V., Gostick E., Adams S., Marincola F. M., Sewell A. K., Altfeld M., Brenchley J. M., Douek D. C., Yang O. O., Brander C., Goldstein H., Kan-Mitchell J., Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope Journal of Immunology 2007 178 12 7756 7766
123. Kan-Mitchell J., Bajcz M., Schaubert K. L., Price D. A., Brenchley J. M., Asher T. E., Douek D. C., Ng H. L., Yang O. O., Rinaldo C. R. Jr., Benito J. M., Bisikirska B., Hegde R., Marincola F. M., Boggiano C., Wilson D., Abrams J., Blondelle S. E., Wilson D. B., Degeneracy and repertoire of the human HIV-1 Gag p1777-85 CTL response Journal of Immunology 2006 176 11 6690 6701
124. Venturi V., Chin H. Y., Asher T. E., Ladell K., Scheinberg P., Bornstein E., van Bockel D., Kelleher A. D., Douek D. C., Price D. A., Davenport M. P., TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV Journal of Immunology 2008 181 11 7853 7862
125. Price D. A., Brenchley J. M., Ruff L. E., Betts M. R., Hill B. J., Roederer M., Koup R. A., Migueles S. A., Gostick E., Wooldridge L., Sewell A. K., Connors M., Douek D. C., Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses Journal of Experimental Medicine 2005 202 10 1349 1361
126. Cole D. K., Edwards E. S., Wynn K. K., Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition The Journal of Immunology 2010 185 2600 2610
127. Cole D. K., Yuan F., Rizkallah P. J., Miles J. J., Gostick E., Price D. A., Gao G. F., Jakobsen B. K., Sewell A. K., Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor Journal of Biological Chemistry 2009 284 40 27281 27289
128. Melenhorst J. J., Scheinberg P., Chattopadhyay P. K., Gostick E., Ladell K., Roederer M., Hensel N. F., Douek D. C., Barrett A. J., Price D. A., High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow Blood 2009 113 10 2238 2244
129. Trautmann L., Rimbert M., Echasserieau K., Saulquin X., Neveu B., Dechanet J., Cerundolo V., Bonneville M., Selection of T cell clones expressing high-affinity public TCRs within human cytomegalovirus-specific CD8 T cell responses Journal of Immunology 2005 175 9 6123 6132
130. Venturi V., Kedzierska K., Price D. A., Doherty P. C., Douek D. C., Turner S. J., Davenport M. P., Sharing of T cell receptors in antigen-specific responses is driven by convergent recombination Proceedings of the National Academy of Sciences of the United States of America 2006 103 49 18691 18696
131. Venturi V., Price D. A., Douek D. C., Davenport M. P., The molecular basis for public T-cell responses? Nature Reviews Immunology 2008 8 3 231 238
132. Dietrich P.-Y., Le Gal F.-A., Dutoit V., Pittet M. J., Trautman L., Zippelius A., Cognet I., Widmer V., Walker P. R., Michielin O., Guillaume P., Connerotte T., Jotereau F., Coulie P. G., Romero P., Cerottini J.-C., Bonneville M., Valmori D., Prevalent role of TCR -chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen Journal of Immunology 2003 170 10 5103 5109
133. Trautmann L., Labarrire N., Jotereau F., Karanikas V., Gervois N., Connerotte T., Coulie P., Bonneville M., Dominant TCR V usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens European Journal of Immunology 2002 32 11 3181 3190
134. Serana F., Sottini A., Caimi L., Palermo B., Natali P. G., Nistic P., Imberti L., Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients Journal of Translational Medicine 2009 7, article no. 21
135. Uchi H., Stan R., Turk M. J., Engelhorn M. E., Rizzuto G. A., Goldberg S. M., Wolchok J. D., Houghton A. N., Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo Advances in Immunology 2006 90 215 241
136. Clay T. M., Custer M. C., McKee M. D., Parkhurst M., Robbins P. F., Kerstann K., Wunderlich J., Rosenberg S. A., Nishimura M. I., Changes in the fine specificity of gp100((209217))-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residue Journal of Immunology 1999 162 3 1749 1755
137. Stuge T. B., Holmes S. P., Saharan S., Tuettenberg A., Roederer M., Weber J. S., Lee P. P., Diversity and recognition efficiency of T cell responses to cancer PLoS Medicine 2004 1 2, article no. e28
138. Le Gal F.-A., Ayyoub M., Dutoit V., Widmer V., Jger E., Cerottini J.-C., Dietrich P.-Y., Valmori D., Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1 Journal of Immunotherapy 2005 28 3 252 257
139. Bendle G. M., Haanen J. B., Schumacher T. N., Preclinical development of T cell receptor gene therapy Current Opinion in Immunology 2009 21 2 209 214
140. Johnson L. A., Morgan R. A., Dudley M. E., Cassard L., Yang J. C., Hughes M. S., Kammula U. S., Royal R. E., Sherry R. M., Wunderlich J. R., Lee C.-C. R., Restifo N. P., Schwarz S. L., Cogdill A. P., Bishop R. J., Kim H., Brewer C. C., Rudy S. F., VanWaes C., Davis J. L., Mathur A., Ripley R. T., Nathan D. A., Laurencot C. M., Rosenberg S. A., Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen Blood 2009 114 3 535 546
141. Schmid D. A., Irving M. B., Posevitz V., Hebeisen M., Posevitz-Fejfar A., Sarria J. -C.F., Gomez-Eerland R., Thome M., Schumacher T. N.M., Romero P., Speiser D. E., Zoete V., Michielin O., Rufer N., Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function Journal of Immunology 2010 184 9 4936 4946
142. Dougan M., Dranoff G., Immune therapy for cancer Annual Review of Immunology 2009 27 83 117